1,704
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Comorbidity among Danish lung cancer patients before and after initial cancer diagnosis

ORCID Icon, , , , &
Article: 1861579 | Received 27 May 2020, Accepted 05 Dec 2020, Published online: 20 Dec 2020

References

  • NORDCAN. 2006. (www.dep.iarc.fr/NORDCAN/DK
  • Iachina M, Green A, Jakobsen E. The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates. BMJ Open. 2014 Feb 12;4(2):e003846. doi:https://doi.org/10.1136/bmjopen-2013-003846. PMID: 24523421; PMCID: PMC3927932).
  • Lüchtenborg M, Jakobsen E, Krasnik M, et al. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer. 2012 Dec;48(18):3386–7.
  • Deleuran T, Thomsen RW, Nørgaard M, et al. Comorbidity and survival of Danish lung cancer patients from 2000–2011: a population-based cohort study. Clin Epidemiol. 2013 Nov 1;5(Suppl 1):31–38.
  • Grose D, Morrison DS, Devereux G, et al. Scottish lung cancer forum. Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment. Postgrad Med J. 2014 Jun;90(1064):305–310. Epub 2014 Mar 27.
  • Iachina M, Jakobsen E, Møller H, et al. The effect of different comorbidities on survival of non-small cells lung cancer patients. Lung. 2015 Apr;193(2):291–297.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619.
  • Dalton SO, Steding-Jessen M, Engholm G, et al. Social inequality and incidence of and survival from lung cancer in a population-based study in Denmark, 1994–2003. Eur J Cancer. 2008 Sep;44(14):1989–1995.
  • Berglund A, Holmberg L, Tishelman C, et al. Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden. Thorax. 2010 Apr;65(4):327–333.
  • Dalton SO, Frederiksen BL, Jacobsen E, et al. Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001–2008. Br J Cancer. 2011 Sep 27;105(7):1042–1048.
  • Dalton SO, Steding-Jessen M, Jakobsen E, et al. Socioeconomic position and survival after lung cancer: influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004–2010. Acta Oncol. 2015 May;54(5):797–804. Epub 2015 Mar 12.
  • Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
  • Pedersen CB. The Danish Civil Registration System. Scand J Pulic Health. 2011;32:183–190.
  • Løkke A, Hilberg O, Tønnesen P, et al. Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998–2010. BMJ Open. 2014 Jan 6;4(1):e004069.
  • Rittig AH, Hilberg O, Ibsen R, et al. Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study. ERJ Open Res. 2019 Oct 21;5(4):00259–2018.
  • Gade Sikjær M, Hilberg O, Ibsen R, et al. Direct and indirect economic and health consequences related to sarcoidosis in Denmark: a national register-based study. Respir Med. 2019;152:7–13.
  • Nilssen Y, Strand TE, Fjellbirkeland L, et al. Lung cancer survival in Norway, 1997–2011: from nihilism to optimism. Eur Respir J. 2016 Jan;47(1):275–287. Epub 2015 Nov 5. Erratum in: Eur Respir J. 2016 Apr;47(4):1297.
  • Sandfeld-Paulsen B, Meldgaard P, Aggerholm-Pedersen N. Comorbidity in lung cancer: a prospective cohort study of self-reported versus register-based comorbidity. J Thorac Oncol. 2018 Jan;13(1):54–62. Epub 2017 Oct 19. PMID: 29056534.
  • Grønberg BH, Sundstrøm S, Kaasa S, et al. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010 Aug 12;46:2225–2234. Epub 2010 May 12.
  • Ganti AK, Siedlik E, Marr AS, et al. Predictive ability of Charlson comorbidity index on outcomes from lung cancer. Am J Clin Oncol. 2011 Dec;34(6):593–596.
  • Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004 Aug 1;22(15):3099–3103.
  • Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003 Mar 1;103(6):792–802.
  • Firat S, Byhardt RW, Gore E. The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies. Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1394–1399. Epub 2010 Jun 18.
  • Janssen-Heijnen ML, Smulders S, Lemmens V, et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax. 2004 Jul;59(7):602–607.
  • Land LH, Dalton SO, Jørgensen TL, et al. Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol Hematol. 2012 Feb;81(2):196–205. Epub 2011 May 4. PMID: 21536452.
  • Boakye D, Rillmann B, Walter V, et al. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2018 Mar;64:30–39. Epub 2018 Feb 10. PMID: 29459248.
  • Søgaard M, Thomsen RW, Bossen KS, et al. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013 Nov 1;5(Suppl 1):3–29. PMID: 24227920; PMCID: PMC3820483.
  • Jakobsen E, Green A, Oesterlind K, et al. Nationwide quality improvement in lung cancer care: the role of the Danish lung cancer group and registry. J Thorac Oncol. 2013;8(10):1238–1247.
  • Jakobsen E, Rasmussen TR. The Danish lung cancer registry. Clin Epidemiol. 2016;8:537–541. [Published 2016 Oct 25].